You're reading the free version. Trader adds the live tape and alerts.
Start tracking
GRCE Buy Disclosure
Opaleye Management Inc. · SEC Form 4 · Filed Oct 16, 2026
Buy
Calculated transaction value
$68.76K
Opaleye Management Inc. 10% owner
GRCE
Grace Therapeutics
GRCE
Transaction date
Oct 16, 2026
Public filing date
Oct 16, 2026
Filing lag
Filed same day
GRCE daily price context
Close on/before transaction
$1.89
Oct 16, 2026
First close after public filing
$1.88
Oct 19, 2026
Return after filing · so far
-3.19%
Through Nov 12, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock, par value $0.0001 per share
- Quantity / price
- 36,347 shares @ $1.89
- SEC ownership
- Indirect
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001493152-26-047473
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$136.18K
Buys / sales
3 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Grace Therapeutics, Inc. GRCE Current | Buy | Oct 16, 2026 | $68.76K |
| Grace Therapeutics, Inc. GRCE | Buy | Oct 15, 2026 | $45.69K |
| Grace Therapeutics, Inc. GRCE | Buy | Oct 14, 2026 | $21.73K |